From new biologics for AD to JAK inhibitors for children with alopecia areata, get the latest updates in pediatric dermatology, here.
Child's Play: Late Breakers in Peds Derm was presented by Elizabeth Swanson, MD, a board certified dermatologist and pediatric dermatologist at Rocky Mountain Hospital for Children in Denver, Colorado. In her presentation, Dr Swanson highlights new FDA-approved biologics for the treatment of atopic dermatitis (AD) in children, Janus kinase (JAK) inhibitors for AD and alopecia areata, and more. The session was part of the 2025 Midwinter Clinical Hawaii Dermatology Conference, held February 15-29, 2025, on the Big Island, Waikoloa Village, HI.